Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma

10 Mar 2023

Abstract excerpt

BACKGROUND: Lung adenocarcinoma (LUAD) is the one of the most common subtypes in lung cancer. Although various targeted therapies have been used in the clinical practice, the 5-year overall survival rate of patients is still low. Thus, it is urgent to identify new therapeutic targets and develop new drugs for the treatment of the LUAD patients. METHODS: Survival analysis was used to identify the prognostic genes....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioinformatics and Genomic Networks
Share to Ferroptosis and cancer prognosis
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36906970
DOI: 10.1016/j.biopha.2023.114486

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinomaPMID 36906970Read ↗

KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung AdenocarcinomaSemantic proximity Read ↗

An Integrated Analysis of Prognostic and Immune Infiltrates for Hub Genes as Potential Survival Indicators in Patients with Lung AdenocarcinomaSemantic proximity Read ↗

Screening of Hub Genes Associated with Lung Adenocarcinoma by Integrated Bioinformatic AnalysisSemantic proximity Read ↗

Integrated computational analysis revealed hub genes in lung adenocarcinomaSemantic proximity Read ↗

Identification of molecular markers associated with diagnosis and prognosis in lung adenocarcinoma by bioinformatics analysisSemantic proximity Read ↗

An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinomaSemantic proximity Read ↗

Novel molecular subtype-based precision therapy improves prognosis for lung adenocarcinoma patientsSemantic proximity Read ↗

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and PrognosisSemantic proximity Read ↗

Unravelling hub genes as potential therapeutic targets in lung cancer using integrated transcriptomic meta-analysis and in silico approachSemantic proximity Read ↗

Network-based Identification of Key Proteins and Repositioning of Drugs for Non-Small Cell Lung CancerSemantic proximity Read ↗

Integrative Bioinformatics Analysis Identified Hub Genes in Association with Development of Lung AdenocarcinomaSemantic proximity Read ↗

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.